Sort
48,018 grants matching “immunotherapy”
Neuroblastoma Tumor Microenvironment: tumor growth and immune regulation
$2,295,320Carol Thiele-Galetto · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
The Immunobiology of Marrow Allografts for Leukemia
$2,294,717Sloan-Kettering Institute For Cancer Res · P01 · FY2003 · CA
Head and Neck Cancer SPORE
$2,293,901Robert L Ferris · University Of Pittsburgh At Pittsburgh · P50 · FY2017 · CA
SPORE in Breast Cancer
$2,293,534Charles M Perou · Univ Of North Carolina Chapel Hill · P50 · FY2020 · CA
Center for Cancer Immunology and Immunotherapy (CCII)
$2,292,575Jun Yan · University Of Louisville · P20 · FY2024 · GM
Defining regulators of immunity to acute infection using CRISPR screens
$2,292,456Arlene H Sharpe · Harvard Medical School · U19 · FY2021 · AI
Clinical trials to prevent Alzheimer's Disease in Down Syndrome
$2,292,447Michael S Rafii · University Of Southern California · R33 · FY2022 · AG
T Cell Costimulatory Pathways: Functions and Interactions
$2,292,094Arlene H Sharpe · Harvard Medical School · P01 · FY2016 · AI
Cancer Center Support Grant (CCSG)
$2,292,005George J Weiner · University Of Iowa · P30 · FY2014 · CA
Pacific Ovarian Cancer Research Consortium
$2,290,683Nicole D. Urban · Fred Hutchinson Cancer Research Center · P50 · FY2009 · CA
Cancer Center Support Grant
$2,290,048Michael J Weber · University Of Virginia · P30 · FY2011 · CA
Safety/Tolerability/Immunogenicity of first-in-human Aβ DNA vaccine, AV-1959D Phase 1 trials in early-stage AD subjects: based on IND18953 cleared by FDA.
$2,288,273Michael G Agadjanyan · Institute For Molecular Medicine · R01 · FY2025 · AG
T Cell Costimulatory Pathways: Functions and Interactions
$2,287,759Arlene H Sharpe · Harvard Medical School · P01 · FY2017 · AI
Adhesion Molecules in Transfusion Biology
$2,287,751Denisa D Wagner · Immune Disease Institute, Inc. · P01 · FY2007 · HL
Clinical trials to prevent Alzheimer's Disease in Down Syndrome
$2,287,306Michael S Rafii · University Of Southern California · R33 · FY2023 · AG
Targeting the Epigenetic and Metabolic Control of EBV-Epithelial Cancers
$2,286,821Paul M. Lieberman · Wistar Institute · P01 · FY2024 · CA
Mayo Clinic Hepatobiliary SPORE
$2,286,710Mark A. Mc Niven · Mayo Clinic Rochester · P50 · FY2025 · CA
Radiation and checkpoint blockade for cancer immune therapy
$2,286,184Robert H Vonderheide · University Of Pennsylvania · P01 · FY2019 · CA
DNA Sequencing and FACS Core Facilities
$2,284,339Paul Robbins · Division Of Basic Sciences - Nci · ZIC · FY2019 · CA
Clinical trials to prevent Alzheimer's Disease in Down Syndrome
$2,284,142Michael S Rafii · University Of Southern California · R33 · FY2024 · AG
p53, Aging, and Cancer
$2,282,517Curtis Harris · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Investigating and targeting apolipoprotein E4 in Down syndrome-associated Alzheimer's disease
$2,282,487Noah Ray Johnson · University Of Colorado Denver · RF1 · FY2023 · AG
Center for Molecular, Cellular, and Translational Immunological Research
$2,282,366William R Green · Dartmouth College · P20 · FY2008 · RR
Center for Molecular, Cellular, and Translational Immunological Research
$2,282,366William R Green · Dartmouth College · P20 · FY2010 · RR
Center for Molecular, Cellular, and Translational Immunological Research
$2,282,366William R Green · Dartmouth College · P20 · FY2009 · RR